Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (107 total)
-
Créateur: Emory
Sujet: General
Type d'élément: Cours en ligne
Date de la dernière mise à jour: 2018-01-08
Description: Ebola Virus Disease: An Evolving Epidemic - Emory University | CourseraExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Fallah MP, Skrip LA.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-01-24
Description: This article reviews the testing of Ebola therapies during the outbreak. -
Créateur: FDA
Sujet: Research
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2022-07-20
Description: Current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. Because a sponsor will probably want to ship the investigational drug to clinical investigators… -
Créateur: FDA
Sujet: Research
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2023-05-12
Description: The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the… -
Créateur: Feldmann, Marc, Ravinder N. Maini, James N. Woody, Stephen T. Holgate, Gregory Winter, Matthew Rowland, Duncan Richards, and Tracy Hussell.
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-09
Description: With more than 81 000 deaths worldwide from coronavirus disease 2019 (COVID-19) by April 8, 2020, it is incumbent on researchers to accelerate clinical trials of any readily available and potentially acceptably safe therapies that could reduce the… -
Créateur: Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK.
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-08-19
Description: The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Créateur: Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2015-09-15
Description: From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. -
Créateur: Furtado, Remo H. M., Otavio Berwanger, Henrique A. Fonseca, Thiago D. Corrêa, Leonardo R. Ferraz, Maura G. Lapa, Fernando G. Zampieri, Viviane C. Veiga, Luciano C. P. Azevedo, Regis G. Rosa, Renato D. Lopes, Alvaro Avezum, Airton L. O. Manoel, Felipe…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-09-08
Description: The efficacy and safety of azithromycin in the treatment of COVID-19 remain uncertain. We assessed whether adding azithromycin to standard of care, which included hydroxychloroquine, would improve clinical outcomes of patients admitted to the… -
Créateur: Geleris, Joshua, Yifei Sun, Jonathan Platt, Jason Zucker, Matthew Baldwin, George Hripcsak, Angelena Labella, Daniel K. Manson, Christine Kubin, R. Graham Barr, Magdalena E. Sobieszczyk, and Neil W. Schluger.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-06-18
Description: Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. -
Créateur: Grein, Jonathan, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L. Green, François-Xavier Lescure, Emanuele Nicastri, Rentaro Oda, Kikuo Yo, Eugenia Quiros-Roldan, Alex Studemeister,…
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-10
Description: Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2.